Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
5
×
national blog main
biotech
life sciences
boston top stories
clinical trials
san francisco blog main
biotech ipos
boston
cancer diagnostics
fda
freenome
grail
liquid biopsy
medical device
national
national top stories
raleigh-durham blog main
rare disease drugs
san diego blog main
san francisco top stories
startups
thrive earlier detection
480 biomedical
abbvie
actavalon
acute myeloid leukemia
aileron therapeutics
aprea therapeutics
arimoclomol
arnold levine
arsenal medical
baker brothers
bluegrass vascular
bob langer
boehringer ingelheim
boulder/denver blog main
bret piatt
cancer
cdg therapeutics
What
company
5
×
developing
5
×
ipo
tests
blood
cancer
investors
million
public
raised
therapeutics
announced
area
based
bay
biopsy
biotech
brings
broader
buildout
business
close
comes
control
debut
detect
disorders
drug
dyne
dyne’s
effect
execs
external
factors
files
firm
firms
founders
genetic
genomic
Language
unset
Current search:
company
×
developing
×
" boston blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Liquid Biopsy Firm Lucence Plans Bay Area Buildout With $20M in Tow
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation
